Roivant Sciences Ltd (ROIV)

Net profit margin

		Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022
Net income (ttm)	US$ in thousands	4,348,922	4,466,420	-981,774	-969,037	-1,009,030	-1,245,475	-1,177,997	-1,094,888	-845,262
Revenue (ttm)	US$ in thousands	90,017	87,063	67,973	44,317	33,312	22,259	36,493	44,730	48,245
Net profit margin		4,831.22%	5,130.10%	-1,444.36%	-2,186.60%	-3,029.03%	-5,595.38%	-3,228.01%	-2,447.77%	-1,752.02%

March 31, 2024 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $4,348,922K ÷ $90,017K
= 4,831.22%

Over the past nine quarters, Roivant Sciences Ltd has reported varying levels of net profit margins. The net profit margin is a key financial ratio that indicates a company's profitability by expressing the net income as a percentage of total revenue.

In the most recent quarter ending March 31, 2024, Roivant Sciences Ltd achieved an exceptionally high net profit margin of 4,831.22%, indicating that the company generated substantial profits relative to its revenue during that period. This could be attributed to effective cost management, increased revenue, or potentially one-off gains.

In the previous quarter ending December 31, 2023, the net profit margin remained relatively high at 5,130.10%, suggesting continued strong profitability. However, it is important to note that in the quarter ending September 30, 2023, the net profit margin was negative at -1,444.36%. A negative net profit margin indicates that the company incurred losses rather than generating profits during that period.

The negative trend continued in the following quarter ending June 30, 2023, with a net profit margin of -2,186.60%, and in the quarter ending March 31, 2023, with a net profit margin of -3,029.03%. These consecutive negative margins raise concerns about the company's financial performance and operational efficiency during that period.

Looking further back in time, Roivant Sciences Ltd also reported negative net profit margins in the quarters ending December 31, 2022, and September 30, 2022. This suggests that the company faced profitability challenges during those periods as well.

Overall, the trend in the net profit margin for Roivant Sciences Ltd over the past nine quarters has been volatile, with periods of strong profitability followed by quarters of significant losses. This fluctuation in profitability highlights the company's exposure to various internal and external factors that can impact its financial performance. Further analysis and monitoring of the company's financial statements and business operations will be necessary to understand the underlying reasons for these fluctuations and assess the company's long-term profitability prospects.